2025
Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention
Khati A, Copenhaver M, Xu R, Altice F, Wickersham J, Gautam K, Paudel K, Shrestha R. Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention. Journal Of Substance Use And Addiction Treatment 2025, 173: 209693. PMID: 40222706, DOI: 10.1016/j.josat.2025.209693.Peer-Reviewed Original ResearchOpioid-dependent PWIDPre-exposure prophylaxisPrEP prescriptionPrEP useInjected drugsOral pre-exposure prophylaxisBehaviours related to sexFollow-up periodOpioid dependencePrEP continuum of careAssociated with higher persistenceFactors associated with persistenceMultivariable ordinal logistic regressionOpioid-dependent peopleDrug useAssess sociodemographic characteristicsPrEP persistenceRelated to sexHIV outbreakContinuum of careEarly 40sParticipantsPrEP continuumHIV preventionHIV
2024
Modeled estimates of HIV-serodifferent couples in tuberculosis-affected households in four sub-Saharan African countries
Zhang M, Tseng A, Anguzu G, Barnabas R, Davis J, Mujugira A, Flaxman A, Ross J. Modeled estimates of HIV-serodifferent couples in tuberculosis-affected households in four sub-Saharan African countries. PLOS Global Public Health 2024, 4: e0002609. PMID: 38696500, PMCID: PMC11065259, DOI: 10.1371/journal.pgph.0002609.Peer-Reviewed Original ResearchHIV serodifferent couplesTB-affected householdsSerodifferent couplesPrEP useSub-Saharan African countriesHIV acquisitionSouth AfricaGeneral populationHIV prevalencePopulation-based household surveyOral pre-exposure prophylaxisPre-exposure prophylaxisGlobal Burden of DiseaseHousehold surveyRisk Factors StudyAfrican countriesBurden of diseaseHouseholdsHigh-burden countriesContact evaluationPrEPGlobal burdenCountriesMeta-analysesTB-HIV
2023
Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study
Strong S, Oldfield B, van den Berg J, Cole C, Biegacki E, Ogbuagu O, Virata M, Chan P, Edelman E. Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study. Preventive Medicine Reports 2023, 37: 102553. PMID: 38282665, PMCID: PMC10810836, DOI: 10.1016/j.pmedr.2023.102553.Peer-Reviewed Original ResearchUnhealthy alcohol usePre-exposure prophylaxisAlcohol reduction interventionsAlcohol useHIV pre-exposure prophylaxisOral pre-exposure prophylaxisAcquisition of HIVAlcohol-related harmPrEP adherencePrEP careTreatment optionsOral formulationReduction interventionsPrEP programMSMPrEPProphylaxisHIVMultimodal approachMenCareAdherenceInterventionSexUnited States
2020
Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs
Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. Journal Of Substance Use And Addiction Treatment 2020, 117: 108058. PMID: 32811633, PMCID: PMC7438607, DOI: 10.1016/j.jsat.2020.108058.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisInjectable pre-exposure prophylaxisLAI-PrEPOral pre-exposure prophylaxisLong-term side effectsSelf-reported HIV risk behaviorsBangkok Tenofovir StudyEvidence-based HIVHigh-risk PWUDImportant key populationHIV-negative peopleOpioid use disorderHIV risk behaviorsHIV prevention effortsAddiction treatment programsDaily PrEPOral PrEPAdherence challengesIndependent correlatesFemale sexClinical trialsHIV preventionIndependent factorsSide effectsUse disorders
2018
Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study
Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. The Lancet HIV 2018, 5: e498-e505. PMID: 29908917, PMCID: PMC6138558, DOI: 10.1016/s2352-3018(18)30097-3.Peer-Reviewed Original ResearchConceptsNew HIV infectionsInjectable PrEPPre-exposure prophylaxisOral PrEPHIV infectionHIV transmissionInjectable pre-exposure prophylaxisOral pre-exposure prophylaxisAbsence of PrEPDaily oral PrEPTime-varying efficacyPhase 3 trialRetention of patientsNational InstituteDiscontinuation ratesSafety trialMacaque modelHIV preventionCumulative numberClinical carePharmacokinetic dataCoverage levelsPotential effectivenessPopulation-level impactInfection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply